Lassa Fever Treatment Market Share

Middle East and African Market Forecasts

The lassa fever treatment market in Middle East and Africa region is estimated to witness the highest growth over the forecast time period on the back of increasing incidences of Lassa fever in the region. The lack of proper sanitation services in the region is also expected to significantly fuel the regional market growth. According to the statistics by the WHO, around 2 billion people do not have basic sanitation facilities, such as toilets, especially in middle and low-income economies. Improving healthcare facilities, backed by increasing investment in the sector is further estimated to boost the market growth. According to the data by the World Bank, USD 520.89 was spent per capita on healthcare in the Middle East and North Africa region, in 2018.

North American Market Statistics

The lassa fever treatment market in the North America region is set to hold a significant revenue share by 2036. The growth of this market can attributed to the account of increasing presence of market players in this product in the North American region. Furthermore, Increasing research and development activities on the treatment of Lassa fever along with expansion of healthcare infrastructure and skilled professionals. The healthcare expenditure in North America is rising which is providing more resources for the development and advancement of Lassa fever treatment. Furthermore, the regulatory environment in North America is supportive of the development of new drugs which is encouraging pharmaceutical companies to invest in Lassa fever research. Besides, increasing demand for personalized medicine, is leading to the development of more targeted and effective treatments for Lassa fever in the North America region.